Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Personal factors that affect disabled people’s access to healthcare in the Bosomtwe District of Ghana

Acheampong E, Nadutey A, Bredu-Darkwa P, et al. Oxford University Press (OUP). Health Promotion International. 2021;
Publication

Snakebite victim profiles and treatment-seeking behaviors in two regions of Kenya: results from a health demographic surveillance system

Larson PS, Ndemwa M, Thomas AF, et al. Springer Science and Business Media LLC. Tropical Medicine and Health. 2022;
Download PDF
Publication

A call for loiasis to be added to the WHO list of neglected tropical diseases

Jacobsen KH, Andress BC, Bhagwat EA, et al. Elsevier BV. The Lancet Infectious Diseases. 2022;
Publication

What can work and how? An overview of evidence-based interventions and delivery strategies to support health and human development from before conception to 20 years

Vaivada T, Lassi ZS, Irfan O, et al. Elsevier BV. The Lancet. 2022;
Publication

Fifty years of struggle to control cutaneous leishmaniasis in the highest endemic county in Iran: A longitudinal observation inferred with interrupted time series model

Aflatoonian M, Sharifi I, Aflatoonian B, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (4) : e0010271.
Download PDF
Publication

Big Pharma, the World Health Organization, and the co-constitution of international policies against river blindness

Guilbaud A. Routledge. Public and Private Welfare in Modern Europe. 2022;
Download PDF
Publication

Climate change and emergency care in Africa: A scoping review

Theron E, Bills CB, Calvello Hynes EJ, et al. Elsevier BV. African Journal of Emergency Medicine. 2022; 12 (2) : 121-128.
Download PDF
Publication

The Gambia has eliminated trachoma as a public health problem: Challenges and successes

Aboe A, Joof BM, Kanyi SK, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (3) : e0010282.
Download PDF
Publication

Scabies affects quality of life in correlation with depression and anxiety

Yıldırım SK, Öğüt ND, Erbağcı E, et al. Research Square Platform LLC. 2022;
Download PDF
Publication

Barriers to cutaneous leishmaniasis care faced by indigenous communities of rural areas in Colombia: a qualitative study

Bautista-Gomez MM, Doerfler J, del Mar Castro M. Springer Science and Business Media LLC. BMC Infectious Diseases. 2022;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 332
  • Page 333
  • Page 334
  • Page 335
  • Current page 336
  • Page 337
  • Page 338
  • Page 339
  • Page 340
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD